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Dr Richard A. Jonas (Washington, DC). I have no disclosures.
Dr Barron, many thanks for sending me the manuscript. This is
obviously a complex area and you have a huge amount of data, so it
was very helpful to be able to look at the manuscript ahead of time.
You are certainly to be congratulated on this additional, ex-
tremely important contribution regarding the challenging problem
of ccTGA. It was just over 20 years ago that Dr Michel Ilbawi in-
troduced the concept of the double switch (DS) procedure and held
out hope for this difficult problem of ccTGA. Until that time the
results of traditional surgery, which left the right ventricle as the
systemic ventricle, resulted in dismal long-term outcomes, as
was so ably documented by Dr Viktor Hraska when he was with
our group in Boston. Although encouraging early results were re-
ported for the DS by Professor Imai’s group at Tokyo Women’s
Medical College and Dr Roger Mee in Melbourne, as well as Dr
Brawn and your group in Birmingham, this most recent analysis1356 The Journal of Thoracic and Cardiovascular Surwill surely lead all of us to rethink which patients are best managed
by this procedure.
I would like to highlight some of the disturbing points that Dr
Barron has just presented to us. First, late left ventricular dysfunc-
tion is not uncommon. Recent reports had already raised that sus-
picion, but what is of greater concern is that late left ventricular
dysfunction cannot be accurately predicted. I think we were all
hopeful that training of the left ventricle at an older age, such as
greater than 12 or 15 years, or the presence of preoperative heart
failure or the presence of postoperative valve dysfunction might
have been predictive of late left ventricular dysfunction. Regretta-
bly, none of this has been documented by the analysis we have just
heard. In fact, this large experience raises the question whether the
fundamental premise that the child with ccTGA must always be
better off with a systemic mLV and a biventricular circulation is
correct.
What is of equal concern to the high incidence of late left ven-
tricular dysfunction is the high incidence of late need for reopera-
tion and reintervention. The DS patients not only had a higher
incidence of late left ventricular dysfunction relative to the RS
patients, but in addition they had a surprisingly high rate of late
aortic valve regurgitation and pulmonary artery problems, partic-
ularly after a Lecompte maneuver. These problems were less fre-
quently seen in the RS patients, but surely this latter option is in
other respects a less desirable option than a true DS since it con-
demns patients to a lifetime of conduit changes. Conduit changes
can be a particular problem when the patient has dextrocardia,
which applied to more than 20% of your patients in this series
and in many other series has applied to as many as one third of
all patients. And for both groups reoperations were needed for
the Senning pathways, both systemic and pulmonary, which leads
to my questions:
First, is there ever a place for a prophylactic DS in the child with
an intact septum and no TR?What sort of associated problems like
a mild degree of Ebstein-like malformation of the TVor congenital
heart block might lead you to do a prophylactic DS?
Dr Barron. Thank you very much for your very fair comments.
I completely agree. It has raised concerns in all our minds about the
long-term management of these patients. Absolutely, it is patient
selection—who needs what operation at what time—that is the
key.
I am not sure whether many people would ever have suggested
that doing a prophylactic DS in a child who is completely well, has
no TR, and a good functioning systemic right ventricle, that put-
ting them through this major maze operation, would be the right
thing to do. So no, I do not think there is any place for prophylactic
DS.
Now, if they have a degree of TR, then it starts to get a bit trick-
ier because the natural history is bad. As soon as they have mod-
erate or greater TR, they are on a bad survival curve, and that is
more difficult. The first thing I would say is that I think there is
a place for a PAB in that situation, because that in itself may treat
the TR and buy some time. You are setting them on that track to-
ward DS at that stage. However, that may well be their best out-
come despite what we are saying here.
Dr Jonas.Would it be fair to say that the bar is shifted slightly
against the DS in terms of these patients who do not have a VSD
and who have an intact septum?gery c December 2011
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DDr Barron. Yes, I think so. That’s a fair comment. Of course,
we are all conscious of the patients in whom symptoms develop.
The more difficult problem is the ones who do not have symptoms
but whose right ventricle does not look good or who have some
TR.
Dr Jonas. Second, how important is dextrocardia as a contrain-
dication to an RS procedure in view of the risk of proximal conduit
compression by the sternum and need for frequent conduit
changes?
Dr Barron. In our series I would not say it has been a major
concern, and we certainly would not regard it as a contraindication
to the DS. Certainly dextrocardia makes the operation technically
more difficult to do, but we can be reassured by the fact that the
operative results for the RS have been very good. I you look at
the incidence, we have only had to actually replace 12 conduits
in thewhole population over the 19 years of this study. So the com-
mitment to lots of operations for conduit replacement does not
seem to be too bad.
We have not analyzed it specifically to look at whether the dex-
trocardia patients are those who have needed more conduit re-
placement, so I could not answer that.
Dr Jonas. Third, I have a question about PAB. To whom do you
now offer left ventricular preparation by PAB? Do you see a role
for PAB as destination therapy to induce septal shift to treat TR
in the patient with an intact septum and low left ventricular
pressure?
Dr Barron. I do not think we would consider PAB unless the
patients had evidence that they were running into trouble, that
they had moderate TR, or that they had some dysfunction or
some signs of dilatation of the mRV. Those are the patients we
would select for banding at that point. I quite agree that the band-
ing itself will cause septal shift and may reduce the TR and symp-
toms in many of the patients.
Whether that will be the destination, I do not think I could an-
swer. I think each patient must be evaluated individually. Once
PAB is done, you are making a commitment that you would be ex-
pecting to take them through a DS. If they remain well with the
PAB on, they should be safe and there is no reason not to just
keep watching them, indefinitely if need be. But in our experience,
with the majority of patients, once TR and right ventricular dilata-
tion have developed, they are going to ultimately get systemic ven-
tricular failure and they will need something.
Dr Jonas. You can certainly make the argument that the left
ventricle is going to manage the banded pressure over the lon-
ger-term. If the TR is stable and the septum remains shifted across,
perhaps in the long-term that would be a more satisfactory out-
come than some of the multiple reinterventions that you have
documented.
Final question: What is the role of the Fontan operation versus
the DS in light of the results that you have presented?The Journal of Thoracic and CarDr Barron. There are certain populations within this group of
patients for whom the Fontan would be a good and a valid alterna-
tive. I do not think there is any role for it in the DS-type population,
because you have not removed the concern of the mRV failing or
the TR becoming a problem. If you take them through a Fontan
program, that risk is still there.
I guess the Fontan is more appropriate in the group of patients
who are in the RS group, in whom you would avoid the whole
problem of having to place a conduit, perhaps the risk of heart
block and the risk of leaving a left ventricle–aortic tunnel. And
you know that the Fontan is a pretty safe operation.
We are all kind of hard-wired to think that if the patients have 2
ventricles, it is a sin to take them through a Fontan circulation, and
that is something we can debate. However, I think the functional
performance and the functional result the patients get with a biven-
tricular repair, which in this case means RS versus the Fontan, is
better with an RS. Thus I would still put my vote for a biventricular
repair with an RS, and I think that is supported by these outcomes.
We know that the Fontan, although safe, has a long-term attrition. I
would argue it might be worse than we are going to see in the RS
group. Certainly there are patients in the RS group who have an
uncommittable VSD, and in those patients I think there is a very
good argument for doing a Fontan rather than a conventional phys-
iologic repair.
Dr Jonas. Thank you. Once again, congratulations, this is going
to be a really important contribution.
Dr Rodolfo A. Neirotti (Cambridge, Mass). Congratulations
for your large number of patients and for being honest in pre-
senting the data in which you have shown some long-term prob-
lems that can be useful for others trying to use the same
approach.
I would like to expand on Richard Jonas’s question, and that
is, the place of the Fontan operation. In patients with ccTGA
and large VSDs, the ventricular dysfunction appears usually after
the septation. In this cohort of patients, after the Fontan opera-
tion, the 2 ventricles function as a large single chamber, with
a single outlet, an anatomy and physiology that may result in
a better ventricular function than when you do the septation
and the DS.
Dr Barron. No, I think that is a fair comment. If you use the
Fontan approach, they will fall into the better series of Fontan out-
comes. However, I still believe that a biventricular repair provides
a better functional result. The results here would support the fact
that so long as they have a suitable anatomy where the Rastelli
is readily performed, the left ventricle can be committed back to
the aorta without causing any obstruction within the ventricle. I
think the functional outcome for those patients would still be supe-
rior than to do a Fontan.
Dr V. S. Reddy. David, I think you can discuss it later because
we are way over time.diovascular Surgery c Volume 142, Number 6 1357
